Dutch medical technology firm Royal Philips has expanded its collaboration with Israel-based Ibex Medical Analytics to enhance AI-enabled digital pathology solutions.
The partnership will focus on integrating AI into digital pathology to enhance efficiency and productivity to improve diagnostic workflows and patient care.
It aims to address the shortage of pathologists and the increasing number of cancer patients.
Philips and Ibex initially partnered in 2021, to enhance the interoperability of their solutions, which enhanced up to 37% productivity in reporting efficiency.
The expanded partnership allows pathology laboratories to use Philips IntelliSite Pathology Solution (PIPS) alongside Ibex’s AI tools for prostate, breast, and gastric cancer diagnostics.
Alverno Laboratories president and CEO Sam Terese said: “The Philips and Ibex solutions are especially beneficial to the diagnosis of cancer cases because they aid our pathologists in making an accurate and quick diagnosis.
“These integrated pathology solutions help us provide the highest possible quality result that any lab can deliver, getting answers back to our clinicians quickly and saving patients sleepless nights, even on complex cases.”
The integration of AI in digital pathology workflows empowers clinicians to deliver objective and reproducible results, addressing the rising demand for pathology-based diagnostics.
The expanded solutions are expected to provide optimised workflows, including AI-powered cancer detection and case prioritisation.
In addition, Philips is also introducing IntelliSite Pathology 6.0, which features new AI capabilities and improved workflows.
The system provides advanced analysis and insights, facilitating a seamless clinical workflow from case management to diagnosis and reporting.
New features include full scan mode for the pathology SG scanner and enhanced scalability.
In collaboration with Amazon Web Services, Philips offers cloud archival services for effective and secure management of digital pathology data.
Medipath innovation, scientific and project management Director Stéphane Rossat said: “The enhanced interoperability between Philips and Ibex platforms, which are now more seamlessly integrated into our diagnostic workflows, will accelerate the adoption of augmented pathology tools in which we strongly believe.
“PIPS 6.0 promises to facilitate adoption by our physicians, thanks to its streamlined navigation and optimized workflows. We are eager to contribute to the evolution toward true digital “cockpits,” which will become the reference interface for our pathologists.”
